Ethnic comparisons of antipsychotic use in schizophrenia

References

• Snowden LR, Cheung FK. Use of inpatient mental health services by members of ethnic minority groups. Am Psychol 1990; 45: 347–355
   PubMed Web of Science ®Google Scholar
• Adebimpe VR. Race, racism, and epidemiological surveys. Hosp Community Psychiatry 1994; 45: 27–31
   PubMedGoogle Scholar
• Lawson WB, Hepler N, Holladay J, Cuffel B. Race as a factor in inpatient and outpatient admissions and diagnosis. Hosp Community Psychiatry 1994; 45: 72–74
   PubMedGoogle Scholar
• Bhui K, Stansfeld S, Hull S, Priebe S, Mole F, Feder G. Ethnic variations in pathways to and use of specialist mental health services in the UK. Systematic review. Br J Psychiatry 2003; 182: 105–116
   PubMed Web of Science ®Google Scholar
• Singh SP, Greenwood NAN, White S, Churchill R. Ethnicity and the Mental Health Act 1983. Br J Psychiatry 2007; 191: 99–105
   PubMed Web of Science ®Google Scholar
• Blanco C, Patel SR, Liu L, et al. National trends in ethnic disparities in mental health care. Med Care 2007; 45: 1012–1019
   PubMed Web of Science ®Google Scholar
• Price N, Glazer W, Morgenstern H. Demographic predictors of the use of injectable versus oral antipsychotic medications in outpatients. Am J Psychiatry 1985; 142: 1491–1492
   PubMed Web of Science ®Google Scholar
• Lloyd K, Moodley P. Psychotropic medication and ethnicity: an inpatient survey. Soc Psychiatry Psychiatr Epidemiol 1992; 27: 95–101
   PubMed Web of Science ®Google Scholar
• Segal SP, Bola JR, Watson MA. Race, quality of care, and antipsychotic prescribing practices in psychiatric emergency services. Psychiatr Serv 1996; 47: 282–286
   PubMed Web of Science ®Google Scholar
• Citrome L, Levine J, Allingham B. Utilization of depot neuroleptic medication in psychiatric inpatients. Psychopharmacol Bull 1996; 32: 321–326
   PubMedGoogle Scholar
• Lehman AF, Steinwachs DM. Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) client survey. Schizophr Bull 1998; 24: 11–20
   PubMed Web of Science ®Google Scholar
• Walkup JT, McAlpine DD, Olfson M, Labay LE, Boyer C, Hansell S. Patients with schizophrenia at risk for excessive antipsychotic dosing. J Clin Psychiatry 2000; 61: 344–348
   PubMed Web of Science ®Google Scholar
• Diaz FJ, De Leon J. Excessive antipsychotic dosing in 2 U.S. State hospitals. J Clin Psychiatry 2002; 63: 998–1003
   PubMed Web of Science ®Google Scholar
• Wang PS, West JC, Tanielian T, Pincus HA. Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders. Schizophr Bull 2000; 26: 451–457
   PubMed Web of Science ®Google Scholar
• Owen RR, Feng W, Thrush CR, Hudson TJ, Austen MA. Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals. Psychiatr Serv 2001; 52: 1523–1525
   PubMed Web of Science ®Google Scholar
• Covell NH, Jackson CT, Evans AC, Essock SM. Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles. Schizophr Bull 2002; 28: 17–29
   PubMed Web of Science ®Google Scholar
• Kuno E, Rothbard AB. Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. Am J Psychiatry 2002; 159: 567–572
   PubMed Web of Science ®Google Scholar
• Mark T, Dirani R, Slade E, Russo P. Access to new medications to treat schizophrenia. J Behav Health Serv Res 2002; 29: 15–29
   PubMed Web of Science ®Google Scholar
• Kreyenbuhl J, Zito JM, Buchanan RW, Soeken KL, Lehman AF. Racial disparity in the pharmacological management of schizophrenia. Schizophr Bull 2003; 29: 183–194
   PubMed Web of Science ®Google Scholar
• Opolka JL, Rascati KL, Brown CM, Gibson PJ. Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine. Psychiatr Serv 2004; 55: 151–156
   PubMed Web of Science ®Google Scholar
• Copeland LA, Zeber JE, Valenstein M, Blow FC. Racial disparity in the use of atypical antipsychotic medications among veterans. Am J Psychiatry 2003; 160: 1817–1822
   PubMed Web of Science ®Google Scholar
• Daumit G, Crum R, Guallar E, et al. Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics and Whites in the United States. Arch Gen Psychiatry 2003; 60: 121–128
   PubMed Web of Science ®Google Scholar
• Kelly DL, Dixon LB, Kreyenbuhl JA, et al. Clozapine utilization and outcomes by race in a public mental health system: –2000. J Clin Psychiatry ; 67 1994; 2006: 1404–1411
   Google Scholar
• Mallinger JB, Fisher SG, Brown T, Lamberti JS. Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia. Psychiatr Serv 2006; 57: 133–136
   PubMed Web of Science ®Google Scholar
• Ministry of Health. The New Zealand Health Strategy. Ministry of Health, WellingtonNew Zealand 2000
   Google Scholar
• Ajwani S, Blakely T, Robson B, Tobias M, Bonne M. Decades of disparity: ethnic mortality trends in New Zealand 1980–1999. Ministry of Health and University of Otago, WellingtonNew Zealand 2003
   Google Scholar
• Ministry of Health. A portrait of health: key results of the 2002/03 New Zealand Health Survey. Ministry of Health, WellingtonNew Zealand 2004
   Google Scholar
• Mental Health Commission. Blueprint for mental health services in New Zealand: how things need to be. Mental Health Commission, WellingtonNew Zealand 1998
   Google Scholar
• Wells JE, Oakley Browne MA, Scott KM, McGee MA, Baxter J, Kokaua J. Te Rau Hinengaro: the New Zealand Mental Health Survey: overview of methods and findings. Aust N Z J Psychiatry 2006; 40: 835–844
   PubMed Web of Science ®Google Scholar
• Statistics New Zealand. 2001Census: National Summary (2001) – reference report. Statistics New Zealand, WellingtonNew Zealand 2001
   Google Scholar
• Ministry of Health. Asian health chart book 2006. Public health intelligence monitoring report no.4. Wellington, New Zealand: Ministry of Health, 2006.
   Google Scholar
• Baxter J, Kokaua J, Wells JE, McGee MA, Oakley Browne MA. Ethnic comparisons of the 12 month prevalence of mental disorders and treatment contact in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust N Z J Psychiatry 2006; 40: 905–913
   PubMed Web of Science ®Google Scholar
• Te Puni Kokiri. Nga ia te oranga hinengaro Maori: trends in Maori mental health 1984–1993. Te Puni Kokiri, Ministry of Maori Development, WellingtonNew Zealand 1996
   Google Scholar
• Edmonds LK, Williams S, Walsh AE. Trends in Maori mental health in Otago. Aust N Z J Psychiatry 2000; 34: 677–683
   PubMed Web of Science ®Google Scholar
• Abas M, Vanderpyl J, Le Prou T, Kydd R, Emery B, Foliaki SA. Psychiatric hospitalization: reasons for admission and alternatives to admission in South Auckland, New Zealand. Aust N Z J Psychiatry 2003; 37: 620–625
   PubMed Web of Science ®Google Scholar
• Gaines P, Bower A, Buckingham B, et al. New Zealand mental health classification and outcomes study: final report. Health Research Council of New Zealand, Auckland 2003
   Google Scholar
• Wheeler A, Robinson E, Robinson G. Admissions to acute psychiatric inpatient services in Auckland, New Zealand: a demographic and diagnostic review. N Z Med J 2005; 118: U1752
   PubMedGoogle Scholar
• Ministry of Health. Looking forward: Strategic directions for the Mental Health Services. Ministry of Health, WellingtonNew Zealand 1994
   Google Scholar
• Ministry of Health. Moving forward: the National Mental Health Plan for more and better services. Ministry of Health, WellingtonNew Zealand 1997
   Google Scholar
• Ministry of Health. Te Tahuhu – improving mental health 2005–2015: the Second New Zealand Mental Health and Addiction Plan. Ministry of Health, WellingtonNew Zealand 2005
   Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association, Washington, DC 2004
   Google Scholar
• Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005; 39:1–30.
   PubMed Web of Science ®Google Scholar
• Chiles JA, Miller AL, Crismon ML, Rush AJ, Krasnoff AS, Shon SS. The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm. Psychiatr Serv 1999; 50: 69–74
   PubMed Web of Science ®Google Scholar
• Lehman AF, Kreyenbuhl J, Buchanan RW, et al. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations. Schizophr Bull ; 30 2003; 2004: 193–217
   Google Scholar
• Miller AL, Hall CS, Buchanan RW, et al. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry 2004; 65: 500–508
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Mental Health. Schizophrenia: core interventions in the treatment of schizophrenia in primary and secondary care. Clinical guideline 1. National Institute for Clinical Excellence: London, 2002
   Google Scholar
• Lehman AF, Steinwachs DM. Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull 1998; 24: 1–10
   PubMed Web of Science ®Google Scholar
• Mental Health Commission. New Zealand's National Mental Health Strategy; review of progress 1994–1999. Mental Health Commission, WellingtonNew Zealand 1999
   Google Scholar
• Walker RA. 2001 demographic profile for Waitemata District Health Board: an analysis of 2001 Census. Auckland: Regional Decision Support Team, Northern DHB Support Agency (NDSA), 2002.
   Google Scholar
• Walker RA. 2001 demographic profile for Counties Manukau District Health Board: an analysis of 2001 Census. Auckland: Regional Decision Support Team, Northern DHB Support Agency (NDSA), 2002.
   Google Scholar
• Walker RA. 2001 demographic profile for Auckland District Health Board: an analysis of 2001 Census. Auckland: Regional Decision Support Team, Northern DHB Support Agency (NDSA), 2002.
   Google Scholar
• Humberstone V, Wheeler A, Lambert T. An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand. Aust N Z J Psychiatry 2004; 38: 240–245
   PubMed Web of Science ®Google Scholar
• Wheeler A, Humberstone V, Robinson E. Impact of audit and feedback on antipsychotic prescribing in schizophrenia J Eval Clin Pract 2008; in press.
   Google Scholar
• Valenstein M, Copeland L, Owen R, Blow F, Visnic S. Delays in adopting evidence-based dosages of conventional antipsychotics. Psychiatr Serv 2001; 52: 1242–1244
   PubMed Web of Science ®Google Scholar
• Walkup JT, McAlpine DD, Olfson M, Labay LE, Boyer C, Hansell S. Patients with schizophrenia at risk for excessive antipsychotic dosing. J Clin Psychiatry 2000; 61: 344–348
   PubMed Web of Science ®Google Scholar
• Sramek J, Roy S, Ahrens T, Pinanong P, Cutler NR, Pi E. Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patients. Hosp Community Psychiatry 1991; 42: 590–592
   PubMedGoogle Scholar
• Jeste DV, Lindamer LA, Evans J, Lacro JP. Relationship of ethnicity and gender to schizophrenia and pharmacology of neuroleptics. Psychopharmacol Bull 1996; 32: 243–251
   PubMedGoogle Scholar
• Ruiz P, Varner RV, Small DR, Johnson BA. Ethnic differences in the neuroleptic treatment of schizophrenia. Psychiatr Q 1999; 70: 163–172
   PubMed Web of Science ®Google Scholar
• Arnold LM, Strakowski SM, Schwiers ML, et al. Sex, ethnicity, and antipsychotic medication use in patients with psychosis. Schizophr Res 2004; 66: 169–175
   PubMed Web of Science ®Google Scholar
• Lin KM, Finder E. Neuroleptic dosage for Asians. Am J Psychiatry 1983; 140: 490–491
   PubMed Web of Science ®Google Scholar
• Collazo Y, Tam R, Sramek J, Herrera J. Neuroleptic dosing in Hispanic and Asian inpatients with schizophrenia. Mt Sinai J Med 1996; 63: 310–313
   PubMedGoogle Scholar
• Ruiz S, Chu P, Sramek J, Rotavu E, Herrera J. Neuroleptic dosing in Asian and Hispanic outpatients with schizophrenia. Mt Sinai J Med 1996; 63: 306–309
   PubMedGoogle Scholar
• Sramek JJ, Sayles MA, Simpson GM. Neuroleptic dosage for Asians: a failure to replicate. Am J Psychiatry 1986; 143: 535–536
   PubMed Web of Science ®Google Scholar
• Potkin SG, Shen Y, Pardes H, et al. Haloperidol concentrations elevated in Chinese patients. Psychiatry Res 1984; 12: 167–172
   PubMed Web of Science ®Google Scholar
• Lin KM, Poland RE, Lau JK, Rubin RT. Haloperidol and prolactin concentrations in Asians and Caucasians. J Clin Psychopharmacol 1988; 8: 195–201
   PubMed Web of Science ®Google Scholar
• Lin KM, Poland RE, Wan YJ, Smith MW, Lesser IM. The evolving science of pharmacogenetics: clinical and ethnic perspectives. Psychopharmacol Bull 1996; 32: 205–217
   PubMedGoogle Scholar
• Matsuda KT, Cho MC, Lin KM, Smith MW, Young AS, Adams JA. Clozapine dosage, serum levels, efficacy, and side-effect profiles: a comparison of Korean-American and Caucasian patients. Psychopharmacol Bull 1996; 32: 253–257
   PubMedGoogle Scholar
• Pinninti NR, Shaila B, Kumar G. Racial bias in the prescription atypical of antipsychotics?. Psychiatr Serv 2003; 54: 110
   PubMed Web of Science ®Google Scholar
• Ministry of Health. Te Puawaitanga: Maori mental health national strategic framework. Ministry of Health, WellingtonNew Zealand 2002
   Google Scholar
• Crawley L, Pulotu-Endemann FK, Stanley-Findlay RTU. Strategic directions for the mental health services for Pacific Islands people. Ministry of Health, WellingtonNew Zealand 1995
   Google Scholar
• Sue S, Fujino DC, Hu LT, Takeuchi DT, Zane NW. Community mental health services for ethnic minority groups: a test of the cultural responsiveness hypothesis. J Consult Clin Psychol 1991; 59: 533–540
   PubMed Web of Science ®Google Scholar
• Stuart GW, Minas IH, Klimidis S, O'Connell S. English language ability and mental health service utilisation: a census. Aust N Z J Psychiatry 1996; 30: 270–277
   PubMed Web of Science ®Google Scholar
• Ziguras S, Lambert TJ, McKenzie DP, Pennella J. The influence of client's ethnicity on psychotropic medication management in community mental health services. Aust N Z J Psychiatry 1999; 33: 882–888
   PubMed Web of Science ®Google Scholar
• Ziguras SJ, Klimidis S, Lambert TJ, Jackson AC. Determinants of anti-psychotic medication compliance in a multicultural population. Community Ment Health J 2001; 37: 273–283
   PubMed Web of Science ®Google Scholar
• Ajwani S, Blakely T, Robson B, Atkinson J, Kiro C. Unlocking the numerator–denominator bias III: adjustment ratios by ethnicity for 1981–1999 mortality data. N Z Med J 2003; 116: U456
   PubMedGoogle Scholar